These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23727087)
21. Dramatic reductions in plaque volumes on maximum statin therapy. Cardiovasc J Afr; 2011; 22(6):344-5. PubMed ID: 22159326 [No Abstract] [Full Text] [Related]
22. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study]. Takeuchi T; Ota H; Hasebe N Nihon Rinsho; 2011 Nov; 69 Suppl 9():336-40. PubMed ID: 22724225 [No Abstract] [Full Text] [Related]
23. An echo-guided case report of rapid regression of unstable mobile thrombus aortic atheroma after aggressive statin and antiplatelet combination therapy. Dʼaloia A; Vizzardi E; Caretta G; Zanini G; Bugatti S; Curnis A; Dei Cas L Am J Ther; 2014; 21(2):e61-5. PubMed ID: 23817345 [TBL] [Abstract][Full Text] [Related]
24. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial). Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123 [TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit. Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644 [TBL] [Abstract][Full Text] [Related]
26. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609 [TBL] [Abstract][Full Text] [Related]
27. Who benefits from statins? Patient or focal plaque? Fujii K; Masuyama T Circ J; 2012; 76(12):2744-5. PubMed ID: 23117744 [No Abstract] [Full Text] [Related]
28. Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease. Hoogeveen RM; Verweij SL; Kaiser Y; Kroon J; Verberne HJ; Vogt L; Moens SJB; Stroes ESG Sci Rep; 2021 Feb; 11(1):4126. PubMed ID: 33602971 [TBL] [Abstract][Full Text] [Related]
29. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI. Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355 [TBL] [Abstract][Full Text] [Related]
30. Beyond greyscale IVUS assessment of progression/regression: it should be simple, but it's not. Mintz GS Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):378-9. PubMed ID: 24448226 [No Abstract] [Full Text] [Related]